TD Waterhouse Canada Inc. Increases Stake in Axon Enterprise, Inc $AXON

TD Waterhouse Canada Inc. increased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 19.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,915 shares of the biotechnology company’s stock after acquiring an additional 1,261 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in Axon Enterprise were worth $4,700,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the stock. Concurrent Investment Advisors LLC grew its holdings in shares of Axon Enterprise by 200.1% in the second quarter. Concurrent Investment Advisors LLC now owns 4,889 shares of the biotechnology company’s stock valued at $2,741,000 after purchasing an additional 3,260 shares during the period. NEOS Investment Management LLC raised its holdings in shares of Axon Enterprise by 12.8% in the 2nd quarter. NEOS Investment Management LLC now owns 58,995 shares of the biotechnology company’s stock valued at $33,073,000 after buying an additional 6,698 shares during the period. Nykredit A S purchased a new stake in Axon Enterprise during the second quarter worth about $21,018,000. B. Metzler seel. Sohn & Co. AG increased its stake in Axon Enterprise by 20.8% during the 2nd quarter. B. Metzler seel. Sohn & Co. AG now owns 6,875 shares of the biotechnology company’s stock worth $3,854,000 after buying an additional 1,183 shares during the period. Finally, SkyOak Wealth LLC acquired a new stake in shares of Axon Enterprise in the second quarter valued at $209,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 16,775 shares of the stock in a transaction on Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the transaction, the president owned 296,974 shares of the company’s stock, valued at $170,590,774.82. This represents a 5.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey C. Kunins sold 9,605 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $626.70, for a total value of $6,019,453.50. Following the transaction, the insider owned 97,761 shares in the company, valued at $61,266,818.70. This trade represents a 8.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 56,380 shares of company stock valued at $32,582,366. 4.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Morgan Stanley raised their target price on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 10th. Barclays raised their price objective on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $721.57.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $515.67 on Monday. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. The business has a fifty day simple moving average of $569.47 and a 200-day simple moving average of $486.64. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $792.16. The stock has a market cap of $41.89 billion, a P/E ratio of 213.97, a P/E/G ratio of 10.06 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. During the same quarter in the prior year, the firm earned $2.12 earnings per share. The company’s revenue for the quarter was up 35.3% compared to the same quarter last year. On average, analysts forecast that Axon Enterprise, Inc will post 2.04 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.